Join Now

Yearly Archives: 2025

Sethera Therapeutics Unveils Breakthrough Enzymatic Platform for Next-Generation Peptide Drugs

SALT LAKE CITY, Utah August 21, 2025 — Sethera Therapeutics today announced publication in the Proceedings of the National Academy of Sciences (PNAS) of peer-reviewed results describing an enzymatic crosslinking platform that forges durable thioether “staples,” locking peptides into drug-like cyclic architectures. The platform works across a broad range of substrates, including sequences built entirely […]

Posted in BioUtah News | Comments Off on Sethera Therapeutics Unveils Breakthrough Enzymatic Platform for Next-Generation Peptide Drugs

Intermountain Health Announces New Children’s Health President and Expands Leadership Role for Hospital President to Build on Legacy of Pediatric Excellence

Intermountain Health Announces New Children’s Health President and Expands Leadership Role for Hospital President to Build on Legacy of Pediatric Excellence

Posted in BioUtah News | Tagged | Comments Off on Intermountain Health Announces New Children’s Health President and Expands Leadership Role for Hospital President to Build on Legacy of Pediatric Excellence

Seek Labs Unveils BioSeeker™

Bioseeker™ is the AI Discovery Engine Powering Seek Labs’ Mission to Outpace Disease with Faster, Smarter Global Health Solutions

Posted in BioUtah News | Tagged | Comments Off on Seek Labs Unveils BioSeeker™

Merit Medical Launches the Prelude Wave Hydrophilic Sheath Introducer with SnapFix Technology

Thin-wall design with superior insertion and unique sheath-securement solution to support successful radial access procedures and may aid in reducing arterial spasm and occlusion

Posted in BioUtah News | Tagged | Comments Off on Merit Medical Launches the Prelude Wave Hydrophilic Sheath Introducer with SnapFix Technology

Purgo Scientific Appoints Veteran MedTech Leader as Chief Executive Officer

James A. Bowman brings decades of experience launching disruptive surgical innovations.

Posted in BioUtah News | Tagged | Comments Off on Purgo Scientific Appoints Veteran MedTech Leader as Chief Executive Officer

Quansys Biosciences Launches Q-View™ Imager Plus: Delivering Reproducible, high-impact ELISA Data with Ease

Quansys Biosciences Launches Q-View™ Imager Plus: Delivering Reproducible, high-impact ELISA Data with Ease

Posted in BioUtah News | Tagged | Comments Off on Quansys Biosciences Launches Q-View™ Imager Plus: Delivering Reproducible, high-impact ELISA Data with Ease

Improving Women’s Health: MobileODT Joins Liger Medical

Improving Women’s Health: MobileODT Joins Liger Medical

Posted in BioUtah News | Tagged | Comments Off on Improving Women’s Health: MobileODT Joins Liger Medical

Wasatch Health Announces Structured Capital Fund

Utah Investment Firm Expands to Deliver Flexible Capital to Transformative Healthcare Companies

Posted in BioUtah News | Tagged | Comments Off on Wasatch Health Announces Structured Capital Fund

Seek Labs Announces Inclusion of Veterinary Diseases in Global Disease Atlas, Accelerating Development of Therapeutics to Bolster Global Protein Supply Chains

Accelerating Development of Therapeutics to Bolster Global Protein Supply Chains

Posted in BioUtah News | Tagged | Comments Off on Seek Labs Announces Inclusion of Veterinary Diseases in Global Disease Atlas, Accelerating Development of Therapeutics to Bolster Global Protein Supply Chains

Nestmedic Selects Curavit Clinical Research as U.S. CRO Partner for Pioneering Prenatal Monitoring Trial

Nestmedic Selects Curavit Clinical Research as U.S. CRO Partner for Pioneering Prenatal Monitoring Trial

Posted in BioUtah News | Tagged | Comments Off on Nestmedic Selects Curavit Clinical Research as U.S. CRO Partner for Pioneering Prenatal Monitoring Trial

Microvascular Therapeutics Celebrates Major Achievements at ASE 2025 Scientific Sessions

Microvascular Therapeutics Celebrates Major Achievements at ASE 2025 Scientific Sessions

Posted in BioUtah News | Tagged | Comments Off on Microvascular Therapeutics Celebrates Major Achievements at ASE 2025 Scientific Sessions

BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)

BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)

Posted in BioUtah News | Tagged | Comments Off on BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)